 |
 |
| DISSS Home | Contact Us |
| ||||||||
|
|
|
|
|
|
| ||
|
|
| ||||||
.gif){kind=spacer} 
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||
Teutsch SM, Churchill RE, eds. Principles and practice of public health surveillance. 2nd ed. New York, NY: Oxford University Press, 2000.
Chin JE, ed. Control of communicable diseases manual. 17th ed. Washington, DC: American Public Health Association, 2000.
Effler P, Ching-Lee M, Bogard A, Ieong M-C, Nekomoto T, Jernigan D. Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods. JAMA 1999;282;1845-50. Available on the Internet at <http://jama.ama-assn.org/issues/v282n19/ffull/joc90534.html>. Accessed September 26, 2002.
Roush S, Birkhead G, Koo D, Cobb A, Fleming D. Mandatory reporting of diseases and conditions by health care professionals and laboratories. JAMA 1999;282:164-70. Available on the Internet at <http://jama.ama-assn.org/issues/v282n2/rfull/joc90413.html>. Accessed November 21, 2000.
Koo D, Caldwell B. The role of providers and health plans in infectious disease surveillance. Eff Clin Pract 1999;2:247-52. Available on the Internet at <http://www.acponline.org/journals/ecp/sepoct99/koo.htm>. Accessed August 3, 2000.
CDC. Framework for program evaluation in public health. MMWR 1999;48(No. RR-11). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4811.pdf>. Accessed November 21, 2000.
CDC. Reporting race and ethnicity data–National Electronic Telecommunications System for Surveillance, 1994-1997. MMWR 1999;48:305-12. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4815.pdf>. Accessed November 21, 2000.
Niskar AS, Koo D. Differences in notifiable infectious disease morbidity among adult women–United States, 1992-1994. J Womens Health 1998;7:451-8.
CDC. Case definitions for infectious conditions under public health surveillance. MMWR 1997;46(No. RR-10).
CDC. Sexually transmitted disease surveillance 1998. Atlanta, GA: US Department of Health and Human Services, Public Health Service, CDC, 1999.
CDC. Manual for the surveillance of vaccine-preventable
diseases. Atlanta, GA: CDC, 1999. Available on the Internet at <http://www.cdc.gov/nip/publications/surv-manual/
begin.pdf>. Accessed August 8, 2000.
CDC. Demographic differences in notifiable infectious disease morbidity–United States, 1992-1994. MMWR 1997;46:637-41. Available on the Internet at <ftp://ftp.cdc.gov/pub/Publications/mmwr/wk/mm4628.pdf>. Accessed November 21, 2000.
CDC. Notifiable disease surveillance and notifiable disease statistics–United States, June 1946 and June 1996. MMWR 1996;45:530-6. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4525.pdf>. Accessed November 21, 2000.
Koo D, Wetterhall S. History and current status of the National Notifiable Diseases Surveillance System. J Public Health Manag Pract 1996;2:4-10.
CDC. Ten leading nationally notifiable infectious diseases–United States, 1995. MMWR 1996;45:883-4. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4541.pdf>. Accessed November 21, 2000.
Martin SM, Bean NH. Data management issues for emerging diseases and new tools for managing surveillance and laboratory data. Emerg Infect Dis 1995;1:124-8. Available on the Internet at <http://www.cdc.gov/ncidod/eid/vol1no4/martin2.htm#top>. Accessed November 21, 2000.
CDC. Manual of procedures for the reporting of nationally notifiable diseases to CDC. Atlanta, GA: US Department of Health and Human Services, Public Health Service, CDC, 1995.
Thacker SB, Stroup DF. Future directions for comprehensive public health surveillance and health information systems in the United States. Am J Epidemiol 1994;140:383-97.
CDC. Use of race and ethnicity in public health surveillance. MMWR 1993;42(No. RR-10). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4210.pdf>. Accessed November 21, 2000.
CDC. Proceedings of the 1992 International Symposium on Public Health Surveillance. MMWR 1992;41(suppl).
CDC. Mandatory reporting of infectious diseases by clinicians and mandatory reporting of occupational diseases by clinicians. MMWR 1990;39(No. RR-9). Available on the Internet at <http://www.cdc.gov/mmwr/preview/mmwrhtml/00001665.htm> and <http://www.cdc.gov/mmwr/preview/mmwrhtml/00001666.htm>. Accessed November 21, 2000.
Thacker SB, Choi K, Brachman PS. The surveillance of infectious diseases. JAMA 1983;249:1181-5.
CDC. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR 1999;48(RR-13). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4813.pdf>. Accessed November 21, 2000.
Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997;337:725-33.
Council of State and Territorial Epidemiologists. CSTE position statement ID-4: National HIV surveillance—addition to the National Public Health Surveillance System. Atlanta, GA: Council of State and Territorial Epidemiologists, 1997.
CDC. Surveillance for adverse events associated with anthrax vaccination—U.S. Department of Defense, 1998-2000. MMWR 2000;49:341-5. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4916.pdf>. Accessed November 21, 2000.
Turnbull PC, Hugh-Jones ME, Cosivi O. World Health Organization activities on anthrax surveillance and control. J Appl Microbiol 1999;87:318-20.
Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax
as a biological weapon: medical and public health management [Review].
JAMA 1999;281:1735-44. Available on the Internet at <http://jama.ama-assn.org/issues/v281n18/ffull/jst80027.html>.
Accessed November 21, 2000.
CDC. Bioterrorism alleging use of anthrax and interim guidelines for management—United States, 1998. MMWR 1999;48;69-74. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4804.pdf>. Accessed November 21, 2000.
Angulo FJ, Getz J, Taylor JP, et al. A large outbreak of botulism: the hazardous baked potato. J Infect Dis 1998;178:172-7.
CDC. Botulism in the United States, 1899-1996: handbook for epidemiologists, clinicians, and laboratory workers. Atlanta, GA: US Department of Health and Human Services, Public Health Service, CDC, 1998. Available on the Internet at <http://www.cdc.gov/ncidod/dbmd/diseaseinfo/botulism.pdf>. Accessed September 25, 2000.
Shapiro RL, Hatheway C, Becher J, Swerdlow D. Botulism surveillance and emergence response: a public health strategy for a global challenge. JAMA 1997;278:433-5.
Yagupsky, P. Detection of brucellae in blood cultures. J Clin Microbiol 1999;37:3437-42.
CDC. Human exposure to Brucella abortus strain RB51—Kansas, 1997. MMWR 1998;47:172-5. Available on the Internet at <ftp://ftp.cdc.gov/pub/Publications/mmwr/wk/mm4709.pdf>. Accessed November 21, 2000.
Chomel BB, DeBess EE, Mangiamele DM, et al. Changing trends in the epidemiology of human brucellosis in California from 1973 to 1992: a shift toward foodborne transmission. J Infect Dis 1994;170:1216-23.
Taylor JP, Perdue JN. The changing epidemiology of human brucellosis in Texas, 1977-1986. Am J Epidemiol 1989;130:160-5.
Mertz KJ, Weiss JB, Webb RM, et al. An investigation of genital ulcers in Jackson, Mississippi, with use of a multiplex polymerase chain reaction assay: high prevalence of chancroid and human immunodeficiency virus infection. J Infect Dis 1998;178:1060-6.
Mertz KJ, Trees D, Levine WC, et al. Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 U.S. cities. The Genital Ulcer Disease Surveillance Group. J Infect Dis 1998;178:1795-8.
DiCarlo RP, Armentor BS, Martin DH. Chancroid epidemiology in New Orleans men. J Infect Dis 1995;172:446-52.
CDC. Chancroid–United States, 1981-1990: evidence for underreporting of cases. In: CDC surveillance summaries, May 29, 1992. MMWR 1992;41(No. SS-3):57-61.
CDC. Sexually transmitted disease surveillance 1999 supplement:
Chlamydia Prevalence Monitoring Project. Atlanta, GA: US Department
of Health and Human Services, CDC, November 2000. Available on the
Internet at <http://www.cdc.gov/nchstp/dstd/Stats_Trends/
99Chlamydia.htm>. Accessed November 21, 2000.
Gaydos CA, Howell MR, Pare B, et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998;339:739-44.
Mertz KJ, McQuillan GM, Levine WC, et al. A pilot study of chlamydial infection in a national household survey. Sex Transm Dis 1998;25:225-8.
CDC. Chlamydia trachomatis genital infections–United States, 1995. MMWR 1997;46:193-8. Available on the Internet at <ftp://ftp.cdc.gov/pub/Publications/mmwr/wk/mm4609.pdf>. Accessed November 21, 2000.
Ackers ML, Quick RE, Drasbeck CJ, Hutwagner L, Tauxe RV. Are there national risk factors for epidemic cholera? The correlation between socioeconomic and demographic indices and cholera incidence in Latin America. Int J Epidemiol 1998;27:330-4.
Mintz ED, Tauxe RV, Levine MM. The global resurgence of cholera. In: Noah ND, O'Mahony M, eds. Communicable disease epidemiology and control. Chichester, England: John Wiley & Sons, 1998:63-104.
Mahon BE, Mintz ED, Greene KD, Wells JG, Tauxe RV. Reported cholera in the United States, 1992-1994: a reflection of global changes in cholera epidemiology. JAMA 1996;276:307-12.
Wachsmuth IK, Blake PA, Olsvik O, eds. Vibrio cholerae and cholera: molecular to global perspectives. Washington, DC: American Society for Microbiology, 1994.
World Health Organization. Guidelines for cholera control. Geneva, Switzerland: World Health Organization, 1993.
Kramer MH, Herwaldt BL, Craun GF, Calderon RL, Juranek DD. Surveillance for waterbornedisease outbreaks–United States, 1993-1994. In: CDC surveillance summaries, April 12, 1996. MMWR 1996;45(No. SS-1). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/ss/ss4501.pdf>. Accessed November 21, 2000.
Juranek DD. Cryptosporidiosis: sources of infection and guidelines for prevention. Clin Infect Dis 1995;21(suppl 1):S57-S61. Also available on the Internet at the following site: <http://www.cdc.gov/ncidod/diseases/crypto/sources.htm>. Accessed September 27, 2000
CDC. Assessing the public health threat associated with waterborne cryptosporidiosis: report of a workshop. MMWR 1995;44(No. RR-6). Also available on the Internet at <http://www.cdc.gov/mmwr/preview/ind95_rr.html>. Accessed September 27, 2000.
Herwaldt BL, Beach MJ. The return of Cyclospora in 1997: another outbreak of cyclosporiasis in North America associated with imported raspberries. Cyclospora Working Group. Ann Intern Med 1999;130:210-20.
CDC. Outbreak of cyclosporiasis–Ontario, Canada, May 1998. MMWR 1998;47:806-9. Available on the Internet at <ftp://ftp.cdc.gov/pub/Publications/mmwr/wk/mm4738.pdf>. Accessed November 21, 2000.
Herwaldt BL, Ackers ML. An outbreak in 1996 of cyclosporiasis associated with imported raspberries. The Cyclospora Working Group. N Engl J Med 1997;336:1548-56.
Bisgard KM, Hardy IR, Popovic T, et al. Respiratory diphtheria in the United States, 1980 through 1995. Am J Public Health 1998;88:787-91.
CDC. Respiratory diphtheria caused by Corynebacterium ulcerans –Terre Haute, Indiana, 1996. MMWR 1997:46:330-2. Available on the Internet at <ftp://ftp.cdc.gov/pub/Publications/mmwr/wk/mm4615.pdf>. Accessed November 21, 2000.
Leek MD, Sivaloganathan S, Devaraj SK, Zamiri I, Griffiths GD, Green MA. Diphtheria with a difference–a rare corynebacterium fatality with associated apoptotic cell death. Histopathology 1990;16:187-9.
Jones TF, Craig AS, Nasci RS, et al. Newly recognized focus of La Crosse encephalitis in Tennessee. Clin Infect Dis 1999;28:93-7.
CDC. Arboviral infections of the central nervous system–United States, 1996-1997. MMWR 1998;47:517-22. Available on the Internet at <ftp://ftp.cdc.gov/pub/Publications/mmwr/wk/mm4725.pdf>. Accessed November 21, 2000.
Szumlas DE, Apperson CS, Hartig PC, Francy DB, Karabatsos N. Seroepidemiology of La Crosse virus infection in humans in western North Carolina. Am J Trop Med Hyg 1996;54:332-7.
Marfin AA, Bleed DM, Lofgren JP, et al. Epidemiologic aspects of a St. Louis encephalitis epidemic in Jefferson County, Arkansas, 1991. Am J Trop Med Hyg 1993;49:30-7.
CDC. PulseNet. The National Molecular Subtyping Network for Foodborne Disease Surveillance. Available on the Internet at <http://www.cdc.gov/ncidod/dbmd/pulsenet/pulsenet.htm>. Accessed August 30, 2000.
Bender JB, Hedberg CW, Besser JM, Boxrud DJ, MacDonald KL, Osterholm MT. Surveillance for Escherichia coli O157:H7 infections in Minnesota by molecular subtyping. N Engl J Med 1997;337:388-94.
Mahon BE, Griffin PM, Mead PS, Tauxe RV. Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli. Emerg Infect Dis 1997;3:409-12. Available on the Internet at <http://www.cdc.gov/ncidod/eid/vol3no3/letters.htm#mahon>. Accessed November 21, 2000.
Slutsker L, Ries AA, Greene KD, Wells JG, Hutwagner L, Griffin PM. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med 1997;126:505-13.
IJdo JW, Meek JI, Cartter ML, et al. The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis. J Infect Dis 2000;181:1388-93.
McQuiston JH, Paddock CD, Holman RC, Childs JE. The human ehrlichioses in the United States [Review]. Emerg Infect Dis 1999;5:635-42. Available on the Internet at <http://www.cdc.gov/ncidod/eid/vol5no5/mcquiston.htm>. Accessed November 21, 2000.
Childs JE, Sumner JW, Nicholson WL, Massung RF, Standaert SM, Paddock CD. Outcome of diagnostic tests using samples from patients with culture-proven human monocytic ehrlichiosis: implications for surveillance. J Clin Microbiol 1999;37:2997-3000.
CDC. Sexually transmitted diseases surveillance 1999 supplement: Gonococcal Isolate Surveillance Project (GISP) annual report –1999. Atlanta, GA: US Department of Health and Human Services, CDC, November 2000. Available on the Internet at <http://www.cdc.gov/nchstp/dstd/Stats_Trends/99GISP.htm>. Accessed November 21, 2000.
CDC. Gonorrhea–United States, 1998. MMWR 2000;49:538-42. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4924.pdf>. Accessed November 21, 2000.
CDC. Increases in unsafe sex and rectal gonorrhea among men who have sex with men–San Francisco, California, 1994-1997. MMWR 1999;48:45-8. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4803.pdf>. Accessed November 21, 2000.
Galil K, Singleton R, Levine OS, et al. Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis 1999;179:101-6.
Bisgard KM, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M. Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis 1998;2:229-37. Available on the Internet at <http://www.cdc.gov/ncidod/eid/vol4no2/bisgard.htm>. Accessed November 21, 2000.
CDC. Progress toward eliminating Haemophilus influenzae type b disease among infants and children–United States, 1987-1997. MMWR 1998;47:993-8. Available on the Internet at <ftp://ftp.cdc.gov/pub/Publications/mmwr/wk/mm4746.pdf>. Accessed November 21, 2000.
CDC. Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1993;42(No. RR-13). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4213.pdf>. Accessed November 21, 2000.
CDC. Hantavirus Pulmonary Syndrome–Panama, 1999-2000. MMWR 2000;49:205-7. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4910.pdf>. Accessed November 21, 2000.
Kitsutani PI, Denton RW, Fritz CL, et al. Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States. Emerg Infect Dis 1999;5:701-5. Available on the Internet at <http://www.cdc.gov/ncidod/eid/vol5no5/kitsutani.htm>. Accessed November 21, 2000.
Monroe MC, Morzunov SP, Johnson AM, et al. Genetic diversity and distribution of Peromyscus -borne hantaviruses in North America. Emerg Infect Dis 1999;5:75-86. Available on the Internet at <http://www.cdc.gov/ncidod/eid/vol5no1/monroe.htm>. Accessed November 21, 2000.
Zavasky D-M, Hjelle B, Peterson M, et al. Acute infection with Sin Nombre hantavirus without pulmonary edema. Clin Infect Dis 1999;29:664-6.
CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(No. RR-12). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4812.pdf>. Accessed November 21, 2000.
Bell BP, Shapiro CN, Alter MJ, et al. The diverse patterns of hepatitis A epidemiology in the United States–implications for vaccination strategies. J Infect Dis 1998;178:1579-84.
Lemon SM, Shapiro CN. The value of immunization against hepatitis A. Infect Agents Dis 1994;3:38-49.
Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine 1992;10(suppl 1):S59–S62.
CDC. Outbreak of cyclosporiasis–Ontario, Canada, May 1998. MMWR 1998;47:806-9. Available on the Internet at <ftp://ftp.cdc.gov/pub/Publications/mmwr/wk/mm4738.pdf>. Accessed November 21, 2000.
Herwaldt BL, Ackers ML. An outbreak in 1996 of cyclosporiasis associated with imported raspberries. The Cyclospora Working Group. N Engl J Med 1997;336:1548-56.
McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United States: The National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Pub Health 1999;89:14-8.
Coleman PJ, McQuillan GM, Moyer LA, Lambert SB, Margolis HS. Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis 1998;178:954-9.
Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control [Review]. Semin Liver Dis 1991;11:84-92.
CDC. Hepatitis B virus: a comprehensive strategy for
eliminating transmission in the United States through universal childhood
vaccination: recommendations of the Immunization Practices Advisory
Committee (ACIP). MMWR 1991;40(No. RR-13):1-19. Available on the Internet
at <http://www.cdc.gov/mmwr/preview/mmwrhtml/
00033405.htm>. Accessed November 21, 2000.
Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.
CDC. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998;47(No. RR-19). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4719.pdf>. Accessed November 21, 2000.
CDC. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR 1999;48(No. RR-13). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4813.pdf>. Accessed November 21, 2000.
Lindegren ML, Byers RH, Jr., Thomas P, et al. Trends
in perinatal transmission of HIV/AIDS in the United States. JAMA 1999;282:531-8.
Available on the Internet at
<http://jama.ama-assn.org/issues/v282n6/rfull/joc81248.html>.
Accessed November 21, 2000.
CDC. HIV/AIDS surveillance report, 1999;11(No. 2). Available on the Internet at <http://www.cdc.gov/hiv/stats/hasr1102.htm>. Accessed September 25, 2000.
CDC. Success in implementing Public Health Service guidelines to reduce perinatal transmission of HIV-Louisiana, Michigan, New Jersey, and South Carolina, 1993, 1995, and 1996. MMWR 1998;47:688-91. Available on the Internet at <ftp://ftp.cdc.gov/pub/Publications/mmwr/wk/mm4733.pdf>. Accessed November 21, 2000.
Kool JL, Carpenter JC, Fields BS. Effect of monochloramine disinfection of municipal drinking water on risk of nosocomial Legionnaires' disease. Lancet 1999;353:272-7.
Fiore AE, Butler JC, Emori TG, Gaynes RP. A survey of methods used to detect nosocomial legionellosis among participants in the National Nosocomial Infections Surveillance System. Infect Control Hosp Epidemiol 1999;20:412-6.
Kool JL, Bergmire-Sweat D, Butler JC, et al. Hospital characteristics associated with colonization of water systems by Legionella and risk of nosocomial legionnaires' disease: a cohort study of 15 hospitals. Infect Control Hosp Epidemiol 1999;20:798-805.
Marston BJ, Lipman HB, Breiman RF. Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality. Arch Intern Med 1994;154:2417-22.
Orloski KA, Hayes EB, Campbell GL, Dennis DT. Surveillance for Lyme disease—United States, 1992-1998. In: CDC surveillance summaries, April 28, 2000. MMWR 2000;49(No. SS-3):1 11. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/ss/ss4903.pdf>. Accessed November 21, 2000.
Hayes EB, Maupin GO, Mount GA, Piesman J. Assessing the prevention effectiveness of local Lyme disease control. J Public Health Manag Pract 1999;5:84-92.
CDC. Recommendations for the use of Lyme disease vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(No. RR-7). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4807.pdf>. Accessed November 21, 2000.
Dennis DT. Epidemiology, ecology, and prevention of Lyme disease. In: Rahn D, Evans J, eds. Lyme disease. Philadelphia, PA: American College of Physicians, 1998:7-34.
Lobel HO, Kozarsky PE. Update on prevention of malaria for travelers. JAMA 1997;278:1767-71.
Zucker JR. Changing patterns of autochthonous malaria transmission in the United States: a review of recent outbreaks. Emerg Infect Dis 1996;2:37-43. Available on the Internet at <http://www.cdc.gov/ncidod/eid/vol2no1/zuckerei.htm>. Accessed November 21, 2000.
Zucker JR, Campbell CC. Malaria. Principles of prevention and treatment [Review]. Infect Dis Clin North Am 1993;7:547-67.
CDC. Measles—United States, 1999. MMWR 2000:49:557-60. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4925.pdf>. Accessed November 21, 2000.
CDC. Epidemiology of measles—United States, 1998. MMWR 1999:48:749-53. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4834.pdf>. Accessed November 21, 2000.
CDC. Measles—United States, 1997. MMWR 1998:47:273-6. Available on the Internet at <ftp://ftp.cdc.gov/pub/Publications/mmwr/wk/mm4714.pdf>. Accessed November 21, 2000.
CDC. Measles, mumps and rubella—vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998:47(No. RR-8). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4708.pdf>. Accessed November 21, 2000.
CDC. Prevention and control of meningococcal disease, and meningococal disease and college students: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000;49(No. RR-7). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4907.pdf>. Accessed November 21, 2000.
CDC. Serogroup W-135 meningococcal disease among travelers returning from Saudi Arabia—United States, 2000. MMWR 2000;49:345-6. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4916.pdf>. Accessed November 21, 2000.
Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992 1996. J Infect Dis 1999;180:1894-901.
Diermayer M, Hedberg K, Hoesly FC, et al. Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain. JAMA 1999;281:1493-7. Available on the Internet at <http://jama.ama-assn.org/issues/v281n16/rfull/joc81215.html>. Accessed November 21, 2000.
CDC. Mumps surveillance-United States, 1988-1993. In: CDC surveillance summaries, August 11, 1995. MMWR 1995;44(No. SS-3). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/ss/ss4403.pdf>. Accessed November 21, 2000.
Briss PA, Fehrs LJ, Parker RA, et al. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis 1994;169:77-82.
Hersh BS, Fine PE, Kent WK, et al. Mumps outbreak in a highly vaccinated population. J Pediatr 1991;119:187-93.
CDC. Recommendations of the Immunization Practices Advisory Committee on Mumps prevention. MMWR 1989;38:388-92, 397-400. Available on the Internet at <http://www.cdc.gov/mmwr/preview/mmwrhtml/00001404.htm>. Accessed November 21, 2000.
Guris D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999;28:1230-7.
CDC. Notice to readers: FDA approval of a fourth acellular pertussis vaccine for use among infants and young children. MMWR 1998;47:934-6. Available on the Internet at <ftp://ftp.cdc.gov/pub/Publications/mmwr/wk/mm4743.pdf>. Accessed November 21, 2000.
CDC. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(No.RR-7). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4607.pdf>. Accessed November 21, 2000.
Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense [Review]. JAMA 2000;283:2281-90.
Dennis DT, Gage KL, Gratz N, Poland JD, Tikhomirov E. Plague manual: epidemiology, distribution, surveillance and control. Geneva, Switzerland: World Health Organization, 1999.
Poland JD, Dennis DT. Plague. In: Evans AS, Brachman PS, eds. Bacterial infections of humans: epidemiology and control. 3rd ed. New York, NY: Plenum Medical Book Company, 1998:545-58.
CDC. Poliomyelitis prevention in the United States: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000;49(No. RR-5). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4905.pdf>. Accessed November 21, 2000.
Prevots DR, Khetsuriani N, Wharton M. Evidence for a decline in the number of vaccine-associated paralytic poliomyelitis cases in the United States following implementation of a sequential poliovirus vaccination schedule, 1997-1998. Presented at the 36th annual meeting of the Infectious Disease Society of America, November 12-15, 1998.
Prevots DR, Sutter RW, Strebel PM, Weibel RE, Cochi SL. Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med 1994;148:479-85.
CDC. Compendium of measures to control Chyamydia psittaci among humans (psittacosis) and pet birds (avian chlamydiosis), 2000. MMWR 2000;49(No. RR-8):1-17. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4908.pdf>. Accessed November 21, 2000.
Moroney JF, Guevara R, Iverson C, et al. Detection of chlamydiosis in a shipment of pet birds, leading to recognition of an outbreak of clinically mild psittacosis in humans. Clin Infect Dis 1998;26:1425-9.
Jorgensen DM. Gestational psittacosis in a Montana sheep rancher. Emerg Infect Dis 1997;2:191-4. Available on the Internet at <http://www.cdc.gov/ncidod/eid/vol3no2/jorgen.htm>. Accessed November 21, 2000.
Wong KH, Skelton SK, Daugharty H. Utility of complement fixation and microimmunofluorescence assays for detecting serologic responses in patients with clinically diagnosed psittacosis. J Clin Microbiol 1994;32:2417-21.
CDC. Compendium of animal rabies prevention and control, 2000: National Association of State and Territorial Public Health Veterinarians, Inc. MMWR 2000;49(No. RR-8):19-30. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4908.pdf>. Accessed November 21, 2000.
CDC. Human rabies prevention–United States, 1999: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(No. RR-1). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4801.pdf>. Accessed November 21, 2000.
Krebs JW, Smith JS, Rupprecht CE, Childs JE. Rabies surveillance in the United States during 1998. J Am Vet Med Assoc 1999;215:1786-98.
Noah DL, Drenzek CL, Smith JS, et al. Epidemiology of human rabies in the United States, 1980 to 1996 [Review]. Ann Intern Med 1998;128:922-30.
Paddock CD, Greer PW, Ferebee TL, et al. Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed diseases. J Infect Dis 1999;179:1469-76.
Thorner AR, Walker DH, Petri WA, Jr. Rocky Mountain spotted fever [Review]. Clin Infect Dis 1998;27:1353-9.
Dalton MJ, Clarke MJ, Holman RC, et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995;52:405-13.
Reef SE, Plotkin S, Cordero JF, et al. Preparing for elimination of Congenital Rubella Syndrome (CRS): summary of a workshop on CRS elimination in the United States. Clin Infect Dis 2000;31:85-95.
CDC. Rubella among Hispanic adults–Kansas, 1998, and Nebraska, 1999. MMWR 2000;49:225-8. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4911.pdf>. Accessed November 21, 2000.
CDC. Rubella outbreak–Westchester County, New York, 1997-1998. MMWR 1999;48:560-3. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4826.pdf>. Accessed November 21, 2000.
Van Beneden CA, Keene WE, Strang RA, et al. Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts. JAMA 1999;281:158-62. Available on the Internet at <http://jama.ama-assn.org/issues/v281n2/rfull/joc80937.html>. Accessed December 8, 2000.
Mahon BE, Slutsker L, Hutwagner L, et al. Consequences in Georgia of a nationwide outbreak of Salmonella infections: what you don't know might hurt you. Am J Public Health 1999;89:31-5.
Glynn MK, Bopp C, Dewitt WK, Dabney P, Mokhtar M, Angulo FJ. Emergence of multidrugresistant Salmonella enterica serotype Typhimurium DT104 infections in the United States. N Engl J Med 1998;338:1333-8.
CDC. Multistate outbreak of Salmonella serotype Agona infections linked to toasted oats cereal–United States, April–May, 1998. MMWR 1998;47:462-4. Available on the Internet at <ftp://ftp.cdc.gov/pub/Publications/mmwr/wk/mm4722.pdf>. Accessed November 21, 2000.
CDC. Outbreak of gastroenteritis associated with an interactive water fountain at a beachside park–Florida, 1999. MMWR 2000;49:565-8. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4925.pdf>. Accessed November 21, 2000.
CDC. Outbreaks of Shigella sonnei infection associated with eating fresh parsley–United States and Canada, July–August 1998. MMWR 1999;48:285-9. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4814.pdf>. Accessed November 21, 2000.
Sobel J, Cameron DN, Ismail J, et al. A prolonged outbreak of Shigella sonnei infections in traditionally observant Jewish communities in North America caused by a molecularly distinct bacterial subtype. J Infect Dis 1998;177:1405-8.
Mohle-Boetani JC, Stapleton M, Finger R, et al. Communitywide shigellosis: control of an outbreak and risk factors in child day-care centers. Am J Public Health 1995;85:812-6.
CDC. Noscomial group A streptococcal infections associated with asymptomatic health-care workers–Maryland and California, 1997. MMWR 1999;48:163-6. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4808.pdf>. Accessed November 21, 2000.
Anonymous. Prevention of invasive group A streptococcal disease among household contacts of case-patients: is prophylaxis warranted? The Working Group on Prevention of Invasive Group A Streptococcal Infections. JAMA 1998;279:1206-10.
Davies HD, McGeer A, Schwartz B, et al, and the Ontario Group A Streptococcal Study Group. Invasive group A streptococcal infections in Ontario, Canada.. N Engl J Med 1996;335:547-54.
Anonymous. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA 1993;269:390-1.
CDC. Active Bacterial Core Surveillance. National Center for Infectious Diseases. Available at <http://www.cdc.gov/ncidod/dbmd/abcs>. Accessed June 23, 2000.
Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance–a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999;18:1-9.
Dowell SF. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics 1998;101(suppl):S163-S184.
CDC. Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working group. MMWR 1996;45(No. RR-1). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4501.pdf>. Accessed November 21, 2000.
Southwick KL, Guidry HM, Weldon MM, Mertz KJ, Berman SM, Levine WC. An epidemic of congenital syphilis in Jefferson County, Texas, 1994-1995: inadequate prenatal syphilis testing after an outbreak in adults. Am J Public Health 1999;89:557-60.
CDC. Congenital syphilis-United States, 1998. MMWR 1999;48:757-61. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4834.pdf>. Accessed November 21, 2000.
CDC. Guidelines for the prevention and control of congenital syphilis. MMWR 1988;37(No. S-1). Available on the Internet at <http://www.cdc.gov/mmwr/preview/mmwrhtml/00026330.htm>. Accessed November 21, 2000.
CDC. Sexually transmitted disease surveillance supplement
1999: syphilis surveillance report. Atlanta, GA: US Department of Health
and Human Services, CDC, November 2000. Available on the Internet at <http://www.cdc.gov/nchstp/dstd/Stats_Trends/
99Syphilis.htm>. Accessed November 21, 2000.
CDC. The National Plan to Eliminate Syphilis from the United States. Atlanta, GA: US Department of Health and Human Services, CDC, National Center for HIV, STD, and TB Prevention, October 1999.
CDC. Primary and secondary syphilis-United States, 1998. MMWR 1999;48:873-8. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4839.pdf>. Accessed November 21, 2000.
CDC. Resurgent bacterial sexually transmitted disease among men who have sex with men-King County, Washington, 1997-1999. MMWR 1999;48:773-7. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4835.pdf>. Accessed November 21, 2000.
Bardenheier B, Prevots DR, Khetsuriani N, Wharton M. Tetanus surveillance-United States, 1995-1997. In: CDC surveillance summaries, July 3, 1998. MMWR 1998;47(No. SS2):1-13. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/ss/ss4702.pdf>. Accessed November 21, 2000.
CDC. Neonatal tetanus-Montana, 1998. MMWR 1998;47:928-30. Available on the Internet at <ftp://ftp.cdc.gov/pub/Publications/mmwr/wk/mm4743.pdf>. Accessed November 21, 2000.
CDC. Tetanus among injecting drug users-California, 1997. MMWR 1998;47:149-51. Available on the Internet at <ftp://ftp.cdc.gov/pub/Publications/mmwr/wk/mm4708.pdf>. Accessed November 21, 2000.
Gergen PJ, McQuillan GM, Kiely M, EzzatiRice TM, Sutter RW, Virella G. A populationbased serologic survey of immunity to tetanus in the United States. N Engl J Med 1995;332:761-6.
Hajjeh RA, Reingold R, Weil A, Shutt K, Schuchat A, Perkins BA. Toxic shock syndrome in the United States: surveillance update, 1979-1996. Emerg Infec Dis 1999;5:807-10. Available on the Internet at <http://www.cdc.gov/ncidod/eid/vol5no6/hajjeh.htm>. Accessed November 21, 2000.
Schuchat A, Broome CV. Toxic shock syndrome and tampons. Epidemiol Rev 1991;13:99-112.
CDC. Reduced incidence of menstrual toxic-shock syndrome-United States, 1980-1990. MMWR 1990;39:421-3. Available on the Internet at <http://www.cdc.gov/mmwr/preview/mmwrhtml/00001651.htm>. Accessed November 21, 2000.
Gaventa S, Reingold AL, Hightower AW, et al. Active surveillance for toxic shock syndrome in the United States, 1986. Rev Infect Dis 1989;11(suppl):S28-S34.
Moorhead A, Grunenwald PE, Dietz VJ, Schantz PM. Trichinellosis in the United States, 1991-1996: declining but not gone. Am J Trop Med Hyg 1999;60:66-9.
CDC. Outbreak of trichinellosis associated with eating cougar jerky-Idaho, 1995. MMWR 1996;45:205-6. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4510.pdf>. Accessed November 21, 2000.
McAuley JB, Michelson MK, Schantz PM. Trichinosis surveillance, United States, 1987-1990. In: CDC surveillance summaries, December 1991. MMWR 1991;40(No. SS-3):35-42.
CDC. Reported tuberculosis in the United States, 1999. Atlanta, GA: US Department of Health and Human Services, CDC, August 2000. Available on the Internet at <http://www.cdc.gov/nchstp/tb/>. Accessed November 21, 2000.
CDC. Progress toward the elimination of tuberculosis-United States, 1998. MMWR 1999;48:732-6. Available on the Internet at <http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4833a2.htm>. Accessed November 21, 2000.
Ackers ML, Puhr ND, Tauxe RV, Mintz ED. Laboratory-based surveillance of Salmonella Serotype Typhi infections in the United States: antimicrobial resistance on the rise. JAMA 2000;283:2668-73.
Mermin JH, Villar R, Carpenter J, et al. A massive epidemic of multidrug-resistant typhoid fever in Tajikistan associated with consumption of municipal water. J Infect Dis 1999;179:1416-22.
Mermin JH, Townes JM, Gerber M, Dolan N, Mintz ED, Tauxe RV. Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med 1998;158:633-8.
CDC. Typhoid immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1994;43(No. RR-14). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4314.pdf>. Accessed November 21, 2000.
CDC. National, state, and urban area vaccination coverage levels among children aged 19-35 months-United States, 1999. MMWR 2000;49:585-9. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4926.pdf>. Accessed November 21, 2000.
CDC. Varicella related deaths-Florida, 1998. MMWR 1999;48:379-81. Available on the Internet at <http://www.cdc.gov/mmwr/PDF/wk/mm4818.pdf>. Accessed November 21, 2000.
CDC. Prevention of varicella: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999:48(No. RR-6). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4806.pdf>. Accessed November 21, 2000.
CDC. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996;45(No. RR-11). Available on the Internet at <http://www.cdc.gov/mmwr/PDF/rr/rr4511.pdf>. Accessed November 21, 2000.
All PDF's require Adobe Acrobat Reader - available here.
 |
|
|
|
|
Privacy Policy | Accessibility CDC Home | Search | Health Topics A-Z This page last updated January 9, 2008 United States
Department of Health and Human Services "Epi Info" is a trademark of the Centers for Disease Control and Prevention (CDC). |
